Guía de Práctica Clínica sobre la Atención Integral a las Personas ...

308. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, SolomonDH, et al. Risk of death in elderly users of conventional vs. atypicalantipsychotic medications. N Engl J Med. 2005; 353(22): 2335-41.309. Zec RF, Burkett NR. Non-pharmacological and pharmacologicaltreatment of the cognitive and behavioral symptoms of Alzheimer disease.NeuroRehabilitation. 2008; 23(5): 425-38.310. De Vugt ME, Stevens F, Aalten P, Lousberg R, Jaspers N, Winkens I,et al. Do caregiver management strategies influence patient behaviourin dementia? Int J Geriatr Psychiatry. 2004; 19(1): 85-92.311. Boeve BF. A review of the non-Alzheimer dementias. J Clin Psychiatry.2006; 67(12): 1985-2001.312. Chamorro García L. Guía de manejo de los trastornos mentales enatención primaria. Barcelona: Psiquiatría editores; 2004.313. Téllez JM, Villena A, Morena S, Pascual P, López-García C. El pacienteagitado. Guías Clínicas. 2005; 5(34). Disponible en: www.fisterra.com314. Feldman HH, Gauthier S, Chertkow H, Conn DK, Freedman M, ChrisM. Progress in clinical neurosciences: Canadian guidelines for the developmentof antidementia therapies: a conceptual summary. Can JNeurol Sci. 2006; 33(1): 6-26.315. Kessler H, Bayer TA, Bach D, Schneider-Axmann T, Supprian T, HerrmannW, et al. Intake of copper has no effect on cognition in patientswith mild Alzheimer’s disease: a pilot phase 2 clinical trial. J NeuralTransm. 2008; 115(8): 1181-7.316. Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associatedwith ginkgo biloba: a case report and systematic review of theliterature: a case report and systematic review of the literature. J GenIntern Med. 2005; 20(7): 657-61.317. Birks J, Grimley EJ. Ginkgo biloba for cognitive impairment and dementia.Cochrane Database Syst Rev. 2009; (1): CD003120.318. Higgins JP, Flicker L. Lecithin for dementia and cognitive impairment.Cochrane Database Syst Rev. 2003; (3): CD001015.319. Klugman A, Sauer J, Tabet N, Howard R. Alpha lipoic acid for dementia.Cochrane Database of Systematic Reviews 2004, Issue 1. Art. N.º:CD004244. DOI: 10.1002/14651858.CD004244.pub2.320. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, et al. Theeffects of omega-3 fatty acids monotherapy in Alzheimer’s disease andmild cognitive impairment: a preliminary randomized double-blindplacebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry.2008; 32(6): 1538-44.321. Lee MS, Yang EJ, Kim JI, Ernst E. Ginseng for cognitive function inAlzheimer’s disease: a systematic review. J Alzheimers Dis. 2009; 18(2):339-44.GUÍA DE PRÁCTICA CLÍNICA SOBRE LA ATENCIÓN INTEGRAL A LAS PERSONASCON ENFERMEDAD DE ALZHEIMER Y OTRAS DEMENCIAS317